Note 7 INTANGIBLE ASSETS AND GOODWILL

Intangible Assets

The components of intangible assets, net at March 31, 2026 and December 31, 2025 were as follows:

 SCHEDULE OF INTANGIBLE ASSETS

The tradenames, licenses and permits and customer relationships intangible assets resulted from the acquisitions of Myrtle, RCHI and Vector. The acquisition of Vector is more fully discussed in Note 5. The tradename associated with Vector of $324,878 is being amortized over 14 years and the tradenames associated with Myrtle and RCHI of $1,582,734 have indefinite lives, the licenses and permits assets have indefinite lives and the customer relationships are being amortized over three to eight years. The Behavioral Health APP, which is under development, is being developed for Myrtle by InnovaQor, Inc. (“InnovaQor”), a related party, as discussed in Note 10, and is not currently expected to be commercialized. The APP being developed is an ongoing communication link between Myrtle and former patients for patient care follow-up and alumni network development.

Not included in the table above is the Epigenetic APP. During the year ended December 31, 2024, the Company recorded an impairment loss for the Epigenetic APP, as the timeline for projected cash flows could no longer support this asset. The Company is in negotiations that, if successful, will lead to the licensing of this technology.

The Company recognized amortization expense on its intangible assets of $22,397 and $3,659 in the three months ended March 31, 2026 and 2025, respectively.

Goodwill

Goodwill was $27.8 million and $27.8 million as of March 31, 2026 and December 31, 2025, respectively. The goodwill resulted from the acquisitions of Myrtle, RCHI and Vector.